Published in Dermatology on January 01, 1994
Characterization of T7-specific ribonucleic acid polymerase. 1. General properties of the enzymatic reaction and the template specificity of the enzyme. J Biol Chem (1973) 5.42
A revised nomenclature for allergy. An EAACI position statement from the EAACI nomenclature task force. Allergy (2001) 5.07
puckered encodes a phosphatase that mediates a feedback loop regulating JNK activity during dorsal closure in Drosophila. Genes Dev (1998) 4.64
Genome-wide, large-scale production of mutant mice by ENU mutagenesis. Nat Genet (2000) 3.92
Clinical validation and guidelines for the SCORAD index: consensus report of the European Task Force on Atopic Dermatitis. Dermatology (1997) 3.48
Characterization of T7-specific ribonucleic acid polymerase. II. Inhibitors of the enzyme and their application to the study of the enzymatic reaction. J Biol Chem (1973) 3.32
Reproducibility of patch tests. J Am Acad Dermatol (1989) 2.65
Incidence and severity of anaphylactoid reactions to colloid volume substitutes. Lancet (1977) 2.60
Practical guide to skin prick tests in allergy to aeroallergens. Allergy (2011) 2.51
Anaphylaxis in patients with mastocytosis: a study on history, clinical features and risk factors in 120 patients. Allergy (2008) 2.18
Allergic Rhinitis and its Impact on Asthma (ARIA): achievements in 10 years and future needs. J Allergy Clin Immunol (2012) 2.17
Informatics and medicine--from molecules to populations. Methods Inf Med (2008) 2.13
Manifestation of atopy is not related to patient's month of birth. Allergy (1993) 2.11
Integration and transcription of mouse mammary tumor virus DNA in rat hepatoma cells. Proc Natl Acad Sci U S A (1979) 2.08
Traffic-related air pollution is associated with atopy in children living in urban areas. Epidemiology (2000) 2.04
UV-induced skin changes due to regular use of commercial sunbeds. Photodermatol Photoimmunol Photomed (2002) 1.81
Standardization of food challenges in patients with immediate reactions to foods--position paper from the European Academy of Allergology and Clinical Immunology. Allergy (2004) 1.81
Alternative medicine in allergies - prevalence, patterns of use, and costs. Allergy (2002) 1.72
Human epidermal Langerhans cells express the high affinity receptor for immunoglobulin E (Fc epsilon RI). J Exp Med (1992) 1.72
Studies of the binding of Escherichia coli RNA polymerase to DNA. V. T7 RNA chain initiation by enzyme-DNA complexes. J Mol Biol (1972) 1.70
A multicenter study on the use of pulsed low-intensity direct current for healing chronic stage II and stage III decubitus ulcers. Arch Dermatol (1993) 1.68
What are melanocytes really doing all day long...? Exp Dermatol (2009) 1.65
From the bench to the bedside: proton pump inhibitors can worsen vitiligo. Br J Dermatol (2007) 1.63
Congenital leukonychia totalis in two brothers. Acta Derm Venereol (1998) 1.58
Prevalence of overweight and obesity in East and West German children in the decade after reunification: population-based series of cross-sectional studies. J Epidemiol Community Health (2008) 1.56
General considerations for skin test procedures in the diagnosis of drug hypersensitivity. Allergy (2002) 1.56
Specific immunotherapy in honeybee venom allergy: a comparative study using aqueous and aluminium hydroxide adsorbed preparations. Allergy (2004) 1.56
Epidemiology of acne in the general population: the risk of smoking. Br J Dermatol (2001) 1.54
EAACI/GA2LEN guideline: aspirin provocation tests for diagnosis of aspirin hypersensitivity. Allergy (2007) 1.53
Can immunoglobulin E-measurement replace challenge tests in allergic rhinoconjunctivits to grass pollen? Clin Exp Allergy (2011) 1.51
Gender difference, sex hormones, and immediate type hypersensitivity reactions. Allergy (2008) 1.50
Reducing the risk of anaphylaxis during anaesthesia: guidelines for clinical practice. J Investig Allergol Clin Immunol (2005) 1.43
Clinical improvement in psoriasis during dithranol/UVB therapy does not correspond with a decrease in elevated serum soluble ICAM-1 levels. Arch Dermatol Res (1993) 1.42
Predicting side-effects in venom immunotherapy by basophil activation? Allergy (2006) 1.42
Invasion of human keratinocytes by Staphylococcus aureus and intracellular bacterial persistence represent haemolysin-independent virulence mechanisms that are followed by features of necrotic and apoptotic keratinocyte cell death. Br J Dermatol (2002) 1.42
Thyroid hormone receptors. Binding characteristics and lack of hormonal dependency for nuclear localization. J Biol Chem (1975) 1.42
The prevalence of positive reactions in the atopy patch test with aeroallergens and food allergens in subjects with atopic eczema: a European multicenter study. Allergy (2004) 1.42
Epidemiology of contact allergy in adults. Allergy (2001) 1.41
The renin angiotensin system and hymenoptera venom anaphylaxis. Clin Exp Allergy (1993) 1.40
Putative association of a TLR9 promoter polymorphism with atopic eczema. Allergy (2007) 1.39
Vitiligo pathogenesis: autoimmune disease, genetic defect, excessive reactive oxygen species, calcium imbalance, or what else? Exp Dermatol (2008) 1.39
Skin test concentrations for systemically administered drugs -- an ENDA/EAACI Drug Allergy Interest Group position paper. Allergy (2013) 1.33
Training phonological awareness with and without explicit attention to articulation. J Exp Child Psychol (1999) 1.33
International Consensus Conference on Atopic Dermatitis II (ICCAD II): clinical update and current treatment strategies. Br J Dermatol (2003) 1.29
Histopathological and epidemiological characteristics of patients with erythema exudativum multiforme major, Stevens-Johnson syndrome and toxic epidermal necrolysis. Br J Dermatol (1996) 1.29
Senile hair graying: H2O2-mediated oxidative stress affects human hair color by blunting methionine sulfoxide repair. FASEB J (2009) 1.25
Standard skin prick testing and sensitization to inhalant allergens across Europe--a survey from the GALEN network. Allergy (2005) 1.25
A new basophil activation test using CD63 and CCR3 in allergy to antibiotics. Clin Exp Allergy (2010) 1.24
Skin testing in patients with hypersensitivity reactions to iodinated contrast media - a European multicenter study. Allergy (2009) 1.24
High local interleukin 5 production in granuloma faciale (eosinophilicum): role of clonally expanded skin-specific CD4+ cells. Br J Dermatol (2005) 1.23
Angiolymphoid hyperplasia with eosinophilia treated with anti-interleukin-5 antibody (mepolizumab). Br J Dermatol (2004) 1.23
GA2LEN (Global Allergy and Asthma European Network) addresses the allergy and asthma 'epidemic'. Allergy (2009) 1.22
Epidemiology of food allergy/food intolerance in adults: associations with other manifestations of atopy. Allergy (2001) 1.20
Airway diseases and allergies in East and West German children during the first 5 years after reunification: time trends and the impact of sulphur dioxide and total suspended particles. Int J Epidemiol (1999) 1.20
ETFAD/EADV eczema task force 2009 position paper on diagnosis and treatment of atopic dermatitis. J Eur Acad Dermatol Venereol (2009) 1.19
Effects of menthol and cold on histamine-induced itch and skin reactions in man. Neurosci Lett (1995) 1.19
Association of a STAT 6 haplotype with elevated serum IgE levels in a population based cohort of white adults. J Med Genet (2004) 1.19
Central activation by histamine-induced itch: analogies to pain processing: a correlational analysis of O-15 H2O positron emission tomography studies. Pain (2001) 1.16
Induction of Fc epsilon R2/CD23 on human epidermal Langerhans cells by human recombinant interleukin 4 and gamma interferon. J Exp Med (1989) 1.16
Management of hypersensitivity reactions to iodinated contrast media. Allergy (2005) 1.16
Melanocytes are not absent in lesional skin of long duration vitiligo. J Pathol (2000) 1.15
Multistep navigation of Langerhans/dendritic cells in and out of the skin. J Allergy Clin Immunol (2001) 1.15
Thiol-sensitive mast cell lines derived from mouse bone marrow respond to a mast cell growth-enhancing activity different from both IL-3 and IL-4. J Immunol (1989) 1.15
Anti-IL-5 recombinant humanized monoclonal antibody (mepolizumab) for the treatment of atopic dermatitis. Allergy (2005) 1.14
Effect of gentian violet, corticosteroid and tar preparations in Staphylococcus-aureus-colonized atopic eczema. Dermatology (1999) 1.14
The role of thioredoxin reductase in the reduction of free radicals at the surface of the epidermis. Biochem Biophys Res Commun (1986) 1.14
Studies of the binding of Escherichia coli RNA polymerase to DNA. 3. Tight binding of RNA polymerase holoenzyme to single-strand breaks in T7 DNA. J Mol Biol (1972) 1.13
[Anaphylaxis following ingestion of coffee, chronic urticaria and analgesics idiosyncrasy]. Hautarzt (1983) 1.12
Serum selenium levels and blood glutathione peroxidase activities in vitiligo. Br J Dermatol (1999) 1.11
High prevalence of superantigens associated with the egc locus in Staphylococcus aureus isolates from patients with atopic eczema. Eur J Clin Microbiol Infect Dis (2003) 1.10
Synthesis of mouse mammary tumor virus ribonucleic acid in isolated nuclei from cultured mammary tumor cells. Biochemistry (1978) 1.10
Occurrence of IgE-bearing epidermal Langerhans cells in atopic eczema: a study of the time course of the lesions and with regard to the IgE serum level. J Invest Dermatol (1989) 1.09
Mediator studies in skin blister fluid from patients with dual skin reactions after intradermal allergen injection. J Allergy Clin Immunol (1982) 1.09
Glutamate receptors on human melanocytes regulate the expression of MiTF. Pigment Cell Res (2006) 1.08
Skin surface pH, stratum corneum hydration, trans-epidermal water loss and skin roughness related to atopic eczema and skin dryness in a population of primary school children. Acta Derm Venereol (2000) 1.08
Influence of short-term exposure to airborne Der p 1 and volatile organic compounds on skin barrier function and dermal blood flow in patients with atopic eczema and healthy individuals. Clin Exp Allergy (2006) 1.07
Individual differences in gains from computer-assisted remedial reading. J Exp Child Psychol (2000) 1.07
Free radical reduction by thioredoxin reductase at the surface of normal and vitiliginous human keratinocytes. J Invest Dermatol (1986) 1.06
New aspects of itch pathophysiology: component analysis of atopic itch using the 'Eppendorf Itch Questionnaire'. Int Arch Allergy Immunol (2001) 1.06
Tripe palms and malignant acanthosis nigricans: cutaneous signs of imminent metastasis in bladder cancer? J Urol (2001) 1.05
The effect of environmental tobacco smoke on eczema and allergic sensitization in children. Br J Dermatol (2004) 1.04
Correlations between histamine-induced wheal, flare and itch. Arch Dermatol Res (1996) 1.04
Skin levels of arachidonic acid-derived inflammatory mediators and histamine in atopic dermatitis and psoriasis. J Invest Dermatol (1986) 1.04
Influence of acupuncture on type I hypersensitivity itch and the wheal and flare response in adults with atopic eczema - a blinded, randomized, placebo-controlled, crossover trial. Allergy (2009) 1.04
Intensive immunosuppression in the treatment of multiple sclerosis. Lancet (1974) 1.04
Investigation of the personality structure in patients with vitiligo and a possible association with impaired catecholamine metabolism. Dermatology (1995) 1.04
Farming, rural lifestyle and atopy in adults from southern Germany--results from the MONICA/KORA study Augsburg. Clin Exp Allergy (2001) 1.03
Influence of airborne nitrogen dioxide or formaldehyde on parameters of skin function and cellular activation in patients with atopic eczema and control subjects. J Allergy Clin Immunol (1998) 1.03
Two ceramide subfractions detectable in Cer(AS) position by HPTLC in skin surface lipids of non-lesional skin of atopic eczema. J Invest Dermatol (1999) 1.02
Association between severity of atopic eczema and degree of sensitization to aeroallergens in schoolchildren. J Allergy Clin Immunol (1999) 1.02
Atopic dermatitis: a disease of general vasoactive mediator dysregulation. Int Arch Allergy Appl Immunol (1979) 1.02
Intravascular persistence of hydroxyethyl starch in man. Eur Surg Res (1976) 1.02
Analysis of the high affinity IgE receptor genes reveals epistatic effects of FCER1A variants on eczema risk. Allergy (2009) 1.01
The influence of cultural and educational factors on the validity of symptom and diagnosis questions for atopic eczema. Br J Dermatol (1998) 1.01
Somatostatin receptor expression, tumour response, and quality of life in patients with advanced hepatocellular carcinoma treated with long-acting octreotide. Br J Cancer (2006) 1.01
Mechanisms of virus-induced asthma exacerbations: state-of-the-art. A GA2LEN and InterAirways document. Allergy (2007) 1.01
Association of CARD15 polymorphisms with atopy-related traits in a population-based cohort of Caucasian adults. Clin Exp Allergy (2005) 1.01
Intake of unsaturated fatty acids and HDL cholesterol levels are associated with manifestations of atopy in adults. Clin Exp Allergy (2003) 1.00
Role of Staphylococcus aureus surface-associated proteins in the attachment to cultured HaCaT keratinocytes in a new adhesion assay. J Invest Dermatol (1998) 1.00